Patent · US Active

Method for determining exposure to mycobacteria

US9506921B2 · kind B2 · utility

1Cited by
3References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2012
Grant dateNov 29, 2016
Priority date
Expiry dateFeb 13, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/20
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of determining the presence or absence in a sample of a biomarker indicative of exposure to mycobacteria, the method comprising: (a) providing a substrate carrying a mycolic acid derived antigen; (b) contacting the substrate with the sample; (c) contacting the substrate with a fluorophore species; (d) creating an evanescent wave at the boundary of the substrate and the sample; (e) detecting the presence or absence of fluorescence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.